These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24366666)

  • 1. cdc-like/dual-specificity tyrosine phosphorylation-regulated kinases inhibitor leucettine L41 induces mTOR-dependent autophagy: implication for Alzheimer's disease.
    Fant X; Durieu E; Chicanne G; Payrastre B; Sbrissa D; Shisheva A; Limanton E; Carreaux F; Bazureau JP; Meijer L
    Mol Pharmacol; 2014 Mar; 85(3):441-50. PubMed ID: 24366666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.
    Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.
    Tahtouh T; Elkins JM; Filippakopoulos P; Soundararajan M; Burgy G; Durieu E; Cochet C; Schmid RS; Lo DC; Delhommel F; Oberholzer AE; Pearl LH; Carreaux F; Bazureau JP; Knapp S; Meijer L
    J Med Chem; 2012 Nov; 55(21):9312-30. PubMed ID: 22998443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines.
    Burgy G; Tahtouh T; Durieu E; Foll-Josselin B; Limanton E; Meijer L; Carreaux F; Bazureau JP
    Eur J Med Chem; 2013 Apr; 62():728-37. PubMed ID: 23454515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
    Debdab M; Carreaux F; Renault S; Soundararajan M; Fedorov O; Filippakopoulos P; Lozach O; Babault L; Tahtouh T; Baratte B; Ogawa Y; Hagiwara M; Eisenreich A; Rauch U; Knapp S; Meijer L; Bazureau JP
    J Med Chem; 2011 Jun; 54(12):4172-86. PubMed ID: 21615147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    Cerniglia GJ; Karar J; Tyagi S; Christofidou-Solomidou M; Rengan R; Koumenis C; Maity A
    Mol Pharmacol; 2012 Dec; 82(6):1230-40. PubMed ID: 22989521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors.
    Tahtouh T; Durieu E; Villiers B; Bruyère C; Nguyen TL; Fant X; Ahn KH; Khurana L; Deau E; Lindberg MF; Sévère E; Miege F; Roche D; Limanton E; L'Helgoual'ch JM; Burgy G; Guiheneuf S; Herault Y; Kendall DA; Carreaux F; Bazureau JP; Meijer L
    J Med Chem; 2022 Jan; 65(2):1396-1417. PubMed ID: 34928152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy.
    Fan S; Zhang B; Luan P; Gu B; Wan Q; Huang X; Liao W; Liu J
    Biomed Res Int; 2015; 2015():161020. PubMed ID: 26583091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma.
    Zhu YR; Min H; Fang JF; Zhou F; Deng XW; Zhang YQ
    Cancer Biol Ther; 2015; 16(4):602-9. PubMed ID: 25869769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
    Weisberg E; Banerji L; Wright RD; Barrett R; Ray A; Moreno D; Catley L; Jiang J; Hall-Meyers E; Sauveur-Michel M; Stone R; Galinsky I; Fox E; Kung AL; Griffin JD
    Blood; 2008 Apr; 111(7):3723-34. PubMed ID: 18184863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.
    Nguyen TL; Duchon A; Manousopoulou A; Loaëc N; Villiers B; Pani G; Karatas M; Mechling AE; Harsan LA; Limanton E; Bazureau JP; Carreaux F; Garbis SD; Meijer L; Herault Y
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells.
    Lee HJ; Lee JO; Lee YW; Kim SA; Seo IH; Han JA; Kang MJ; Kim SJ; Cho YH; Park JJ; Choi JI; Park SH; Kim HS
    Int J Neuropsychopharmacol; 2019 Jun; 22(6):402-414. PubMed ID: 31125414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy.
    Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X
    Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway.
    Yue Z; Guan X; Chao R; Huang C; Li D; Yang P; Liu S; Hasegawa T; Guo J; Li M
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31340526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases.
    Loaëc N; Attanasio E; Villiers B; Durieu E; Tahtouh T; Cam M; Davis RA; Alencar A; Roué M; Bourguet-Kondracki ML; Proksch P; Limanton E; Guiheneuf S; Carreaux F; Bazureau JP; Klautau M; Meijer L
    Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 29039762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M
    Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors.
    Echeverry N; Ziltener G; Barbone D; Weder W; Stahel RA; Broaddus VC; Felley-Bosco E
    Cell Death Dis; 2015 May; 6(5):e1757. PubMed ID: 25950487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors.
    Akin D; Wang SK; Habibzadegah-Tari P; Law B; Ostrov D; Li M; Yin XM; Kim JS; Horenstein N; Dunn WA
    Autophagy; 2014; 10(11):2021-35. PubMed ID: 25483883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice.
    Souchet B; Audrain M; Billard JM; Dairou J; Fol R; Orefice NS; Tada S; Gu Y; Dufayet-Chaffaud G; Limanton E; Carreaux F; Bazureau JP; Alves S; Meijer L; Janel N; Braudeau J; Cartier N
    Acta Neuropathol Commun; 2019 Mar; 7(1):46. PubMed ID: 30885273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.